Navigation Links
Dendreon Reports Third Quarter 2010 Financial Results
Date:11/3/2010

to place undue reliance on the forward-looking statements contained in this press release. All forward-looking statements are based on information currently available to Dendreon on the date hereof, and Dendreon undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this press release, except as required by law. DENDREON CORPORATIONCONSOLIDATED STATEMENTS OF OPERATIONS (in thousands, except per share amounts)Three months ended September 30,Nine months ended September 30,2010200920102009(unaudited)Revenue

$
20,219$
25$
23,050$
80Cost of revenue

12,433-15,125-Gross profit

7,786257,92580Operating expenses:Research and development

13,54116,49463,69841,613Selling, general and administrative

74,1359,301150,05022,126Total operating expenses

87,67625,795213,74863,739Loss from operations

(79,890)(25,770)(205,823)(63,659)Interest income

369196947725Interest expense

(191)(606)(615)(1,930)Loss from valuation of warrant liability

-(19,371)(142,567)(122,788)Net loss before income tax benefit

(79,712)(45,551)(348,058)(187,652)Income tax benefit

411-411-Net loss

$
(79,301)$
(45,551)$
(347,647)$  (187,652)Basic and diluted net loss per share

$
(0.56)$
(0.40)$
(2.54)$
(1.79)Shares used in computation of basic anddiluted net loss per share

141,996113,447136,735105,096September 30,December 31,20102009Balance Sheet Data:Cash and cash equivalents

$
78,907$
409,829Short-term investments

196,106167,116Long-term investments

17,71129,441Trade accounts receivable

12,028-Prepaid antigen costs

26,23418,975Inventory

11,9541,882Total  assets

690,531735,415Warrant liability

-132,953Convertible senior subordinated notes

52,53552,535Total stockholders' equity

538,193503,564
'/>"/>

SOURCE Dendreon Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Dendreon Announces Presentation of PROVENGE Data at the 25th International Society for Biological Therapy of Cancer Annual Meeting
2. Dendreon Statement on CMS National Coverage Analysis
3. Dendreon Announces Presentation of PROVENGE Data at the American Urological Association Annual Meeting
4. Dendreon Presents Updated IMPACT Results Confirming PROVENGE Improves Overall Survival in Patients With Metastatic Castrate-Resistant Prostate Cancer
5. Dendreon Reports Fourth Quarter and 2009 Year End Financial Results
6. Dendreon Announces Election of Ian Clark and Pedro Granadillo to Board of Directors
7. Dendreon Reports PROVENGE Regulatory and Commercialization Progress and Future Pipeline Plans at Analyst Event
8. Dendreon Presents Preclinical Data Demonstrating Activity of TRPM8 Agonist, D-3263, in Benign Prostatic Hyperplasia
9. Dendreon Initiates Phase 1 Clinical Trial of Small Molecule Targeting TRPM8 in Cancer
10. Dendreon to Hold a Conference Call Tomorrow at 9:00 AM ET to Discuss Final Results of Phase 3 PROVENGE IMPACT Trial
11. Dendreon Presents Integrated Analysis of Clinical Data from NEUVENGE Trials at Chemotherapy Foundation Symposium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... YORK , May 5, 2015  IBM Watson ... is collaborating with more than a dozen leading cancer ... and personalize treatment options for their patients. The institutes ... capabilities to reduce from weeks to minutes the ability ... and gather relevant information from medical literature to personalize ...
(Date:5/5/2015)... Pa. , May 5, 2015  The preclinical ... leader in pharmacokinetic testing of drugs and safety testing ... , Associate Director of Preclinical Studies, presented at this ... Vision and Ophthalmology (ARVO) in Denver, CO. ... was "Safety Assessment of a Novel, Cross-Linked, Bio-Absorbable Carboxymethyl ...
(Date:5/5/2015)... EAST LYME, Conn. , May 5, 2015 /PRNewswire/ ... used lab equipment in North America, has named industry veteran ... President of Business Development. Becorest will be based out ... office where her role will include expanding the company,s ... new strategic partnership opportunities. "ALT has been ...
Breaking Medicine Technology:Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 2Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 3Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 4Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 5Clinicians Tap Watson to Accelerate DNA Analysis and Inform Personalized Treatment Options for Patients 6Dr. Glen Gum of Absorption Systems Presents at The Association for Research in Vision and Ophthalmology (ARVO) Meeting 2Dr. Glen Gum of Absorption Systems Presents at The Association for Research in Vision and Ophthalmology (ARVO) Meeting 3ALT Names Anggie Becorest Senior Vice President of Business Development 2
...  TheraBiogen, Inc. (OTC BB: TRAB), a manufacturer and distributor ... of allergies, cold and flu symptoms and migraine headaches, ... Flu brand is receiving through the ongoing Social Media ... new homeopathic product, Thera Max® Cold and Flu into ...
... 2012  Essentialis, Inc., today announced Phase 2b trial results ... triglyceride (TG) levels by 30 to 40 percent in ... Triglycerides [VHTG]). The study included an arm combining DCCR ... the combination arm, DCCR was shown to be additive ...
Cached Medicine Technology:Thera Max® Cold and Flu Brand Receives Great Benefits from Its Ongoing Social Media Marketing Awareness Program 2Thera Max® Cold and Flu Brand Receives Great Benefits from Its Ongoing Social Media Marketing Awareness Program 3Phase 2b Trial Shows Unique Lipid Efficacy Profile of Novel Compound to Reduce Elevated Triglyceride Levels 2Phase 2b Trial Shows Unique Lipid Efficacy Profile of Novel Compound to Reduce Elevated Triglyceride Levels 3
(Date:5/5/2015)... The global lab automation market is ... Million in 2014, at an estimated CAGR of 6.7% ... automation market on the basis of equipment and software, ... the basis of application, Lab Automation Market is classified ... solutions. Drug discovery is a major application of the ...
(Date:5/5/2015)... TX (PRWEB) May 05, 2015 ... selected C.R. Bard Inc., a leading multinational developer, ... in the fields of vascular, urology, oncology and ... 2015 Vanguard Award. The Vanguard Award recognizes ... employee wellness programs among Viverae’s significant client base. ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 Dr. Patricia ... pulmonary hypertension (PH). A pulmonologist and pulmonary hypertension specialist ... was attending a work event when an initial idea ... “I was sitting in the audience at the 2010 ... team of healthcare providers – were recalling their climb ...
(Date:5/5/2015)... (PRWEB) May 05, 2015 In a April ... The Herald-Times , the Missouri State Highway Patrol (MSHP) ... Methamphetamine production or use for the second year in a ... to the FBI, reported 1,469 incidents in 2014 alone, around ... only around 2% of the US Population calls Indiana home, ...
(Date:5/5/2015)... 05, 2015 ProTexting, LLC – ... to deploy Mobile Engagement Campaigns and other Mobile solutions, ... clients can now leverage the power of Mobile Marketing ... syncing subscribers’ e-mail addresses into the Constant Contact Platform. ... that the growing trend of multi-channel marketing would become ...
Breaking Medicine News(10 mins):Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 2Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 3Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 4Health News:Global Lab Automation Market Forecast to 2020: Research Based on Equipment & Software, Applications, Type of Automation and End Users 5Health News:Viverae® Honors C. R. Bard, Inc. with 2015 Vanguard Award 2Health News:World PH Day: Team PHenomenal Hope Races to Spread the Word about Pulmonary Hypertension 2Health News:A Forever Recovery Releases New Information on the Epidemic Rise Of Methamphetamine Abuse in Midwest America 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 2Health News:ProTexting SMS Mobile Marketing platform integrates with Constant Contact 3
... Parents offered genetic testing to predict their risks of ... children. That is the finding of a new study ... online April 18). The study authors note these and ... chose predictive genetic tests for themselves and for their children, ...
... the first time, scientists have made star-shaped, biodegradable polymers ... the spheres are injected with cells into wounds, these ... new tissue. Developing this nanofiber sphere as ... of the cell is a very significant advance in ...
... Steven Reinberg HealthDay Reporter , FRIDAY, April 15 ... lies may be showing early signs of dementia, researchers from ... may help doctors diagnose which type of dementia a patient ... "The different dementia patients tended to have difficulty identifying ...
... Meat and poultry sold in the United States is widely ... bacteria that can cause serious illnesses in humans, a new ... to S. aureus range from mild skin infections ... In the new nationwide study, researchers analyzed 136 samples ...
... HealthDay Reporter , FRIDAY, April 15 (HealthDay News) -- Is ... in the Journal of the American Medical Association , ... suggested the latter when it found a reduced risk of ... therapy. This seemed to contradict years of cautions ...
... 15, 2011) Strains of genital herpes in Africa ... States, researchers at Harvard Medical School report, a striking ... preventing HIV transmission in a region staggered by the ... testing mouse model strains of the disease against vaccine ...
Cached Medicine News:Health News:Study: Parents likely to embrace predictive genetic testing for their children if offered 2Health News:Study: Parents likely to embrace predictive genetic testing for their children if offered 3Health News:Researchers inject nanofiber spheres carrying cells into wounds to grow tissue 2Health News:Inability to Spot Lies, Sarcasm May Warn of Dementia 2Health News:Inability to Spot Lies, Sarcasm May Warn of Dementia 3Health News:Drug-Resistant Staph Bacteria Found in Meat, Poultry Nationwide 2Health News:Drug-Resistant Staph Bacteria Found in Meat, Poultry Nationwide 3Health News:Estrogen's Role in Breast Cancer Can Fluctuate 2Health News:Estrogen's Role in Breast Cancer Can Fluctuate 3Health News:Genital herpes more virulent in Africa than in US 2Health News:Genital herpes more virulent in Africa than in US 3
... This unique system uses prolene as thread-guide ... The hollow Ritleng Probe is inserted into the ... fed through it. The probe is then withdrawn ... mm 0.64 mm diam silicone tubing into place. ...
To maintain the conjunctival cul-de-sacs after enucleation or evisceration without hindering lid closure....
... Ultra-thin collarette conforms to natural anatomy ... Pre-loaded on disposable inserter/dilator instrument for ease ... Slim Mini and Slim Petite plugs offer ... The Slim plugs are made of the ...
For use with Crawford Intubation Systems....
Medicine Products: